IL34 and hepatocellular carcinoma: Previous study showed that CD138 could enhance the activation of CSF1‐R signal pathways mediated by IL‐34,29 implying that IL‐34 may mainly activate the downstream signal pathways and associated molecules of CSF1‐R when interacted with CSF1‐R and CD138 in HCC cells.